Popular Trials
Hormone Therapy
Intranasal Oxytocin (IN-OXT) +1 More for Prader-Willi Syndrome
Recruiting0 awardsPhase 2
Bronx, New York
This trial is testing if intranasal OXT (a hormone) is better than placebo at treating symptoms of PWS (a genetic disorder that includes hyperphagia, or excessive hunger). The trial will measure if OXT affects eating behaviors, repetitive behaviors, weight and body composition, quality of life, and hormone levels. If OXT is superior to placebo, this will add to the current knowledge that OXT is an effective treatment for hyperphagia and other symptoms of PWS.
Behavioral Intervention
Oxytocin + COPE Therapy for Alcoholism and PTSD
Recruiting0 awardsPhase 2
Charleston, South Carolina
This trial will compare oxytocin to a placebo in reducing symptoms of alcohol use disorder and post-traumatic stress disorder in veterans receiving COPE therapy. Brain scans will be used to examine potential mechanisms of change.
Popular Filters
Trials With No Placebo
Hormone Therapy
Oxytocin Nasal Spray for Frontotemporal Dementia
Recruiting3 awardsPhase 2
Los Angeles, California
This trial is testing the safety and effects of oxytocin given as a nasal spray to people with frontotemporal dementia or Pick's disease, compared to a placebo. Approximately 112 patients will be enrolled at 15 centers in the US and Canada, and will be given either oxytocin or the placebo nasal spray. The trial will happen in two phases, first testing different doses of oxytocin to see which is most effective, and then randomly assigning patients in the second phase to either the most effective dose of oxytocin or the placebo.
Device
Outpatient vs Inpatient Foley Balloon for Labor Induction
Recruiting3 awards7 criteria
Los Angeles, California
This trial is testing whether it's better to induce labor in the hospital with a transcervical foley catheter, or to do it outpatient with removal of the transcervical foley catheter. The goal is to see if the outpatient group spends less time in the hospital.
Procedure
Induction of Labor for Pregnancy
Recruiting1 award3 criteria
Tacoma, Washington
Primary outcome: to evaluate the effect of elective induction of labor (IOL), at 39 weeks gestation, on cesarean delivery rates in nulliparous women compared to expectant management (EM). Secondary outcomes: to evaluate differences in the mean number of clinic visits/antepartum tests avoided with IOL, to compare the differences in utilization of inpatient resources (mean duration of inpatient stay, mean duration of labor), and to evaluate the effect of IOL on the risk of urinary/anal incontinence and sexual dysfunction as analyzed using previously validated measurements. We will evaluate differences in the rate of cervical change once active labor is diagnosed, and the time from completion of active labor, defined as complete dilation and complete effacement, to the delivery of fetus (definition of second stage of active labor). Furthermore, other secondary outcomes to be evaluated include comparisons between IOL and EM in regards to the occurence of chorioamnionitis, stillbirth, operative vaginal delivery, and meconium stained amniotic fluid. An evaluation of the predictive value of cervical length and Bishop score for vaginal delivery will also be examined.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.